Evidence map›Paper›PMID 23177541›Full record

ArticleThe American journal of medicine2013

Respiratory impairment in older persons: when less means more.

Carlos A Vaz Fragoso, Thomas M Gill, Gail McAvay, Philip H Quanjer, Peter H Van Ness, John Concato

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The American journal of medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. GPs should not try to detect mild COPD.NPJ primary care respiratory medicine · 2020
    Article
  6. FEVRespiratory care · 2020
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Phenotype of Spirometric Impairment in an Aging Population.American journal of respiratory and critical care medicine · 2016
    Article
  13. Review
  14. Phenotype of normal spirometry in an aging population.American journal of respiratory and critical care medicine · 2015
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Carlos A Vaz FragosoVeterans Affairs Clinical Epidemiology Research Center, West Haven, CT 06250-8025, USA. carlos.fragoso@yale.edu
Thomas M Gill
Gail McAvay
Philip H Quanjer
Peter H Van Ness
John Concato
Yale University · USDepartment of Veterans Affairs · AU

Funding

Yale Study Support Suite (YES3): Dashboard and Web Portal Software Supporting Research Workflow through integrated, customizable REDCap External ModulesP30AG021342 · NIA · YALE UNIVERSITY · PI Albert C Shaw · 2002 to 2026
$37.9M
Research Training in Disability &Disabling DisordersK24AG021507 · NIA · YALE UNIVERSITY · PI GILL, THOMAS MICHAEL · 2003 to 2012
$1.6M
"Defining Chronic Obstructive Pulmonary Disease in Older Persons"R03AG037051 · NIA · YALE UNIVERSITY · PI FRAGOSO, CARLOS A. VAZ · 2010 to 2011
$133k
NIA NIH HHS K24 AG021507NIA NIH HHS K24AG021507NIA NIH HHS P30 AG021342NIA NIH HHS P30AG2134NIA NIH HHS R03 AG037051NIA NIH HHS R03AG037051
6 · The paper itself

Abstract

backgroundAmong older persons, within the clinical context of respiratory symptoms and mobility, evidence suggests that improvements are warranted regarding the current approach for identifying respiratory impairment (ie, a reduction in pulmonary function).

methodsAmong 3583 white participants aged 65 to 80 years (Cardiovascular Health Study), we calculated the prevalence of respiratory impairment using the current spirometric standard from the Global Initiative for Obstructive Lung Disease (GOLD) and an alternative spirometric approach termed "lambda-mu-sigma" (LMS). Results for GOLD- and LMS-defined respiratory impairment were evaluated for their (cross-sectional) association with respiratory symptoms and gait speed, and for the 5-year cumulative incidence probability of mobility disability.

resultsThe prevalence of respiratory impairment was 49.7% (1780/3583) when using the GOLD and 23.2% (831/3583) when using LMS. Differences in prevalence were most evident among participants who had no respiratory symptoms, with respiratory impairment classified more often by the GOLD (38.1% [326/855]) than LMS (12.3% [105/855]), as well as among participants who had normal gait speed, with respiratory impairment classified more often by the GOLD (46.4% [1003/2164]) than LMS (19.3% [417/2164]). Conversely, the 5-year cumulative incidence probability of mobility disability for respiratory impairment was higher for LMS than GOLD (0.313 and 0.249 for never-smokers, and 0.352 and 0.289 for ever-smokers, respectively), but was similar for normal spirometry by LMS or GOLD (0.193 and 0.185 for never-smokers, and 0.219 and 0.216 for ever-smokers, respectively).

conclusionsAmong older persons, the LMS approach (vs the GOLD approach) classifies respiratory impairment less frequently in those who are asymptomatic and is more strongly associated with mobility disability.

Indexed as

AgedAged, 80 and overFemaleGaitHumansMaleMobility LimitationPrevalenceRespiratory InsufficiencyRetrospective StudiesSpirometryUnited States

Identifiers

PMID23177541
PMCPMC3529831
OpenAlexW2095391733

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.